SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001564590-18-005719
Filing Date
2018-03-15
Accepted
2018-03-15 07:30:43
Documents
3
Period of Report
2018-03-15
Items
Item 2.02: Results of Operations and Financial Condition
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K 031518 albo-8k_20180315.htm 8-K 25272
2 EX-99.1 albo-ex991_14.htm EX-99.1 205293
3 GRAPHIC g201803150323543958573.jpg GRAPHIC 9597
  Complete submission text file 0001564590-18-005719.txt   245176
Mailing Address 10 POST OFFICE SQUARE SUITE 502 SOUTH BOSTON MA 02109
Business Address 10 POST OFFICE SQUARE SUITE 502 SOUTH BOSTON MA 02109 857-415-4774
ALBIREO PHARMA, INC. (Filer) CIK: 0001322505 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-33451 | Film No.: 18691058
SIC: 2834 Pharmaceutical Preparations
Assistant Director 1